Published in Cephalalgia on November 01, 2008
Medication overuse headache in Scandinavia--comments and questions. Cephalalgia (2010) 0.75
Evidence that the newly cloned low-density-lipoprotein receptor related protein (LRP) is the alpha 2-macroglobulin receptor. FEBS Lett (1990) 1.65
Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet (1999) 1.52
Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain (1999) 1.43
Pressure-sensitive devices. Pain (1995) 1.38
Increased pain sensitivity is not a risk factor but a consequence of frequent headache: a population-based follow-up study. Pain (2007) 1.27
Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia (2006) 1.20
Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain (2000) 1.09
Frequency of headache is related to sensitization: a population study. Pain (2006) 1.02
Muscle hardness in patients with chronic tension-type headache: relation to actual headache state. Pain (1999) 0.96
Increased muscular and cutaneous pain sensitivity in cephalic region in patients with chronic tension-type headache. Eur J Neurol (2005) 0.95
What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information? J Headache Pain (2011) 0.91
Increased prevalence of tension-type headache over a 12-year period is related to increased pain sensitivity. A population study. Cephalalgia (2007) 0.91
Abnormal pain processing in chronic tension-type headache: a high-density EEG brain mapping study. Brain (2008) 0.90
Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology (2000) 0.88
Nitric oxide-induced headache in patients with chronic tension-type headache. Brain (2000) 0.88
Muscular factors are of importance in tension-type headache. Headache (1998) 0.87
Familial occurrence of chronic tension-type headache. Cephalalgia (1999) 0.87
In vivo evidence of altered skeletal muscle blood flow in chronic tension-type headache. Brain (2002) 0.87
Comparison of first degree relatives and spouses of people with chronic tension headache. BMJ (1997) 0.87
Tender points are not sites of ongoing inflammation -in vivo evidence in patients with chronic tension-type headache. Cephalalgia (2003) 0.86
311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attack and in a migraine-free period. Cephalalgia (1996) 0.86
Possible mechanisms of pain perception in patients with episodic tension-type headache. A new experimental model of myofascial pain. Cephalalgia (2004) 0.84
Measurement of muscle hardness: a methodological study. Cephalalgia (1998) 0.84
Evaluation and proposal for optimalization of neurophysiological tests in migraine: part 1--electrophysiological tests. Cephalalgia (2007) 0.82
The usefulness and applicability of a basic headache diary before first consultation: results of a pilot study conducted in two centres. Cephalalgia (2008) 0.82
Glyceryl trinitrate may trigger endogenous nitric oxide production in patients with chronic tension-type headache. Cephalalgia (2004) 0.82
Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial. Cephalalgia (2009) 0.81
Induction of prolonged tenderness in patients with tension-type headache by means of a new experimental model of myofascial pain. Eur J Neurol (2003) 0.81
Pain sensitivity in pericranial and extracranial regions. Cephalalgia (2003) 0.80
Possible mechanisms of glyceryl-trinitrate-induced immediate headache in patients with chronic tension-type headache. Cephalalgia (2000) 0.79
[Inhibition of nitric oxide synthase has an analgesic effect in chronic pain]. Ugeskr Laeger (2000) 0.78
Evaluation and proposal for optimization of neurophysiological tests in migraine: part 2--neuroimaging and the nitroglycerin test. Cephalalgia (2007) 0.78
A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia (2006) 0.77
Migrainous infarction: a Nordic multicenter study. Eur J Neurol (2011) 0.76
Calcitonin gene-related peptide levels during nitric oxide-induced headache in patients with chronic tension-type headache. Eur J Neurol (2001) 0.76
Experimental induction of muscle tenderness and headache in tension-type headache patients. Cephalalgia (2005) 0.75
Medication overuse headache in Scandinavia--comments and questions. Cephalalgia (2010) 0.75
Abnormal brain processing of pain in migraine without aura: a high-density EEG brain mapping study. Cephalalgia (2010) 0.75
Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache. Pain (1999) 0.75